Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The two dimeric forms of RNase A.

S Sorrentino1, R Barone, E Bucci

  • 1Dipartimento di Chimica Organica e Biologica, Università di Napoli Federico II, Via Mezzocannone 16, 80134, Naples, Italy.

FEBS Letters
|January 29, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Editorial Expression of Concern: Two novel human anti-ErbB2 immunoagents are active on trastuzumab-resistant tumours.

British journal of cancer·2026
Same author

Influence of KRAS mutations on clinical outcome in patients with curatively resected stage III colon cancer treated with adjuvant chemotherapy.

European review for medical and pharmacological sciences·2020
Same author

Hormonal and metabolic gender differences in a cohort of myotonic dystrophy type 1 subjects: a retrospective, case-control study.

Journal of endocrinological investigation·2019
Same author

Behavioural and physiological indicators of shelter dogs' welfare: reflections on the no-kill policy on free-ranging dogs in Italy revisited on the basis of 15 years of implementation.

Physiology & behavior·2014
Same author

Fluorescence intensity and anisotropy decays of the intrinsic tryptophan emission of hemoglobin measured with a 10-GHz fluorometer using front-face geometry on a free liquid surface.

Journal of fluorescence·2013
Same author

A novel fully human antitumour immunoRNase targeting ErbB2-positive tumours.

British journal of cancer·2011
Same journal

Investigating transcription factor dynamics in health and disease using FRAP.

FEBS letters·2026
Same journal

Regulation of CFTR stability at the plasma membrane-Mechanisms and therapeutic opportunities in cystic fibrosis.

FEBS letters·2026
Same journal

Identification of a Shiga toxin A-derived peptide internalized into Gb3 receptor-bearing cells via interaction with the Shiga toxin B subunit.

FEBS letters·2026
Same journal

The dual role of lectins in cancer-immunotherapy tools and therapeutic targets.

FEBS letters·2026
Same journal

Decoding the dynamic extracellular matrix in cancer-3D models and bioscaffolds rewire the rules of tumor progression.

FEBS letters·2026
Same journal

Extending the classical sequence-structure-function paradigm through protein dynamics and context-dependent behavior.

FEBS letters·2026
See all related articles

Two forms of dimeric ribonuclease A (RNase A) were found to have distinct structural and functional properties. This challenges previous observations, suggesting a re-evaluation of RNase A dimer characterization is needed.

Area of Science:

  • Biochemistry
  • Structural Biology
  • Enzymology

Background:

  • Dimeric ribonuclease A (RNase A) prepared by lyophilization from acetic acid was previously separated into two forms without detectable differences.
  • A dimeric RNase A structure was determined by X-ray crystallography in 1998.

Purpose of the Study:

  • To investigate potential structural and functional differences between the two forms of dimeric RNase A.
  • To re-evaluate the characterization of dimeric RNase A based on new findings.

Main Methods:

  • Analysis of dimeric RNase A forms.
  • X-ray crystallography (as previously performed).
  • Biochemical assays to assess function.

Main Results:

Related Experiment Videos

  • The two forms of dimeric RNase A exhibit distinct structural and functional properties.
  • The previously determined crystal structure may represent a specific, lesser form of the dimer.

    • Conclusions:

    • Dimeric RNase A exists in forms with discernible structural and functional variations.
    • The 1998 crystal structure likely corresponds to the lesser form of dimeric RNase A, necessitating further research into the greater form.